»ç¾÷ºÐ¾ß
¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.
- Ȩ
- »ç¾÷ºÐ¾ß
- »ç¾÷ºÐ¾ß1
»ç¾÷ºÐ¾ß1
Regulatory Affairs, Pre-clinical service
- drug testing,(pre)clinical service, drug development ¼ºñ½ºµî ºÐ¾ß¿¡¼ °íÇ°Áú ¼ºñ½º¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù.
- ±¹³»¹× ±¹Á¦ÀûÀÎ ±âÁØ¿¡ ¸ÂÃç ÀǾàÇ°°³¹ßÀ» À§ÇÑ ÀûÀýÇÑ active ingradient¿Í formulationÀ» ãÀ» ¼ö ÀÖµµ·Ï µ½°íÀÖ½À´Ï´Ù.
1) Method development/validation,transfer method, batch release
2) Pharmacological study, PK, PD, TK, GLP, Identification of unknown impurities
3) In-vitro testing(In-vitro release testing, in-vitro permeation testing)
4) API sourcing: recommend related supply of API ; projects based on requirement
5) API synthesis development, stability studies(GMP, ICH)
6) Small scale synthesis, formulation development